Research Article
Improvement by Medication Less than Expected in Parkinson’s Disease: Blinded Evaluation of Levodopa Response
Table 2
Demographic data for PD with LDCT over and under 30% improvement.
| ||||||||||||||||||||||||||||||||||||||||||||||||
PD LDCT ≤30%, PD acute levodopa challenge test with a change less than or equal to 30% improvement of UPDRS III; PD LDCT >30%, PD acute levodopa challenge test with more than 30% improvement of UPDRS III; MoCA, Montreal Cognitive Assessment. If participants had ≤12 years of education one point were added to the total MoCA score if < 30 to correct for education effects as recommended by the original validation study [9]. Three PD and three controls had ≤12 years of education and all three PD had 1 point added to their total score but only one control due to a score below 30. The median scores of MoCA for PD groups divided after the measured effect were both 27 ( 0.596). All values are reported as the median (minimum, maximum) or absolute frequency (relative frequency in %). |